These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Impact of viral dose and major histocompatibility complex class IB haplotype on viral outcome in mauritian cynomolgus monkeys vaccinated with Tat upon challenge with simian/human immunodeficiency virus SHIV89.6P. Cafaro A, Bellino S, Titti F, Maggiorella MT, Sernicola L, Wiseman RW, Venzon D, Karl JA, O'Connor D, Monini P, Robert-Guroff M, Ensoli B. J Virol; 2010 Sep; 84(17):8953-8. PubMed ID: 20554774 [Abstract] [Full Text] [Related]
43. Plasma levels of the chemokine RANTES in macaque monkeys infected with pathogenic and non-pathogenic SIV/HIV-1 chimeric viruses at an early stage of infection. Kwofie TB, Haga T, Iida T, Hayami M, Miura T. J Vet Med Sci; 2000 Dec; 62(12):1311-2. PubMed ID: 11193348 [Abstract] [Full Text] [Related]
44. Effect of productive in vitro human immunodeficiency virus or simian immunodeficiency virus infection on telomerase activity in lymphoid and nonlymphoid cells. Bostik P, Dodd GL, Patel SS, Kadivar H, Ansari AA. J Infect Dis; 2002 Apr 01; 185(7):999-1001; author reply 1001-2. PubMed ID: 11920329 [No Abstract] [Full Text] [Related]
45. Cytokine kinetics in the plasma of monkeys infected with pathogenic and nonpathogenic simian and human immunodeficiency chimeric viruses at an early stage of infection. Kwofie TB, Haga T, Iida T, Hayami M, Miura T. Microbiol Immunol; 2001 Apr 01; 45(5):399-402. PubMed ID: 11471829 [Abstract] [Full Text] [Related]
49. Rapid viral decay in simian immunodeficiency virus-infected macaques receiving quadruple antiretroviral therapy. Brandin E, Thorstensson R, Bonhoeffer S, Albert J. J Virol; 2006 Oct 01; 80(19):9861-4. PubMed ID: 16973590 [Abstract] [Full Text] [Related]
50. Rapid and irreversible CD4+ T-cell depletion induced by the highly pathogenic simian/human immunodeficiency virus SHIV(DH12R) is systemic and synchronous. Igarashi T, Brown CR, Byrum RA, Nishimura Y, Endo Y, Plishka RJ, Buckler C, Buckler-White A, Miller G, Hirsch VM, Martin MA. J Virol; 2002 Jan 01; 76(1):379-91. PubMed ID: 11739702 [Abstract] [Full Text] [Related]
51. Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. Matano T, Shibata R, Siemon C, Connors M, Lane HC, Martin MA. J Virol; 1998 Jan 01; 72(1):164-9. PubMed ID: 9420212 [Abstract] [Full Text] [Related]
52. Comparative histopathological studies in the early stages of acute pathogenic and nonpathogenic SHIV-infected lymphoid organs. Shimada T, Suzuki H, Motohara M, Kuwata T, Ibuki K, Ui M, Iida T, Fukumoto M, Miura T, Hayami M. Virology; 2003 Feb 15; 306(2):334-46. PubMed ID: 12642106 [Abstract] [Full Text] [Related]
53. T cell receptor excision circles as markers for recent thymic emigrants: basic aspects, technical approach, and guidelines for interpretation. Hazenberg MD, Verschuren MC, Hamann D, Miedema F, van Dongen JJ. J Mol Med (Berl); 2001 Nov 15; 79(11):631-40. PubMed ID: 11715066 [Abstract] [Full Text] [Related]
56. Applying T-cell receptor excision circles and immunoglobulin κ-deleting recombination excision circles to patients with primary immunodeficiency diseases. Lee WI, Huang JL, Lin SJ, Yeh KW, Chen LC, Ou LS, Yao TC, Jaing TH, Shih YF, Tseng TY, Lin YL. Ann Med; 2014 Nov 15; 46(7):555-65. PubMed ID: 25109505 [Abstract] [Full Text] [Related]
57. CTL responses to HIV and SIV: wrestling with smoke. John M, Mallal S. Nat Immunol; 2005 Mar 15; 6(3):232-4. PubMed ID: 15716970 [No Abstract] [Full Text] [Related]